Paris Vail

1.1k total citations
15 papers, 739 citations indexed

About

Paris Vail is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paris Vail has authored 15 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paris Vail's work include Cancer Genomics and Diagnostics (8 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Advanced Breast Cancer Therapies (6 papers). Paris Vail is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Advanced Breast Cancer Therapies (6 papers). Paris Vail collaborates with scholars based in United States, Canada and United Kingdom. Paris Vail's co-authors include Erik S. Knudsen, Agnieszka K. Witkiewicz, Sejin Chung, Vishnu Kumarasamy, Uthra Balaji, Ram Nambiar, Jack Hutcheson, Vladimir Makarov, Timothy A. Chan and Steven D. Leach and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Oncogene.

In The Last Decade

Paris Vail

15 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paris Vail United States	14	506	260	239	203	100	15	739
Smruthi Vijayaraghavan United States	10	571 1.1×	412 1.6×	352 1.5×	126 0.6×	110 1.1×	15	914
Rebecca Watters United States	12	217 0.4×	232 0.9×	211 0.9×	139 0.7×	80 0.8×	25	519
Borbála Székely Hungary	12	528 1.0×	187 0.7×	170 0.7×	249 1.2×	174 1.7×	31	717
Georgios Skliris Canada	8	475 0.9×	419 1.6×	257 1.1×	98 0.5×	147 1.5×	8	835
Louis‐François Plassa France	12	549 1.1×	398 1.5×	111 0.5×	377 1.9×	46 0.5×	14	834
Vincenza Carafa Switzerland	12	379 0.7×	397 1.5×	108 0.5×	180 0.9×	147 1.5×	15	801
Adrian P. Rybak Canada	12	265 0.5×	450 1.7×	174 0.7×	157 0.8×	55 0.6×	17	644
Peter Čamaj Germany	16	355 0.7×	507 1.9×	78 0.3×	279 1.4×	81 0.8×	22	788
J. Baselga Spain	10	399 0.8×	312 1.2×	139 0.6×	188 0.9×	46 0.5×	25	649
Naoe Taira Nihira Japan	10	622 1.2×	551 2.1×	286 1.2×	131 0.6×	258 2.6×	13	1.1k

Countries citing papers authored by Paris Vail

Since Specialization

Citations

This map shows the geographic impact of Paris Vail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paris Vail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paris Vail more than expected).

Fields of papers citing papers by Paris Vail

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paris Vail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paris Vail. The network helps show where Paris Vail may publish in the future.

Co-authorship network of co-authors of Paris Vail

This figure shows the co-authorship network connecting the top 25 collaborators of Paris Vail. A scholar is included among the top collaborators of Paris Vail based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paris Vail. Paris Vail is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Knudsen, Erik S., Vishnu Kumarasamy, Ram Nambiar, et al.. (2022). CDK/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilities. Cell Reports. 38(9). 110448–110448. 78 indexed citations

Knudsen, Erik S., Vishnu Kumarasamy, Sejin Chung, et al.. (2020). Targeting dual signalling pathways in concert with immune checkpoints for the treatment of pancreatic cancer. Gut. 70(1). 127–138. 59 indexed citations

Kumarasamy, Vishnu, Paris Vail, Ram Nambiar, Agnieszka K. Witkiewicz, & Erik S. Knudsen. (2020). Functional Determinants of Cell Cycle Plasticity and Sensitivity to CDK4/6 Inhibition. Cancer Research. 81(5). 1347–1360. 42 indexed citations

Weinberg, Benjamin A., Hongkun Wang, Agnieszka K. Witkiewicz, et al.. (2020). A Phase I Study of Ribociclib Plus Everolimus in Patients with Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy. SHILAP Revista de lepidopterología. 6(1). 45–54. 18 indexed citations

Vail, Paris, et al.. (2019). Interrogating Mutant Allele Expression via Customized Reference Genomes to Define Influential Cancer Mutations. Scientific Reports. 9(1). 12766–12766. 5 indexed citations

Knudsen, Erik S., Vishnu Kumarasamy, Jared Sivinski, et al.. (2019). Cell cycle plasticity driven by MTOR signaling: integral resistance to CDK4/6 inhibition in patient-derived models of pancreatic cancer. Oncogene. 38(18). 3355–3370. 46 indexed citations

Chung, Sejin, Paris Vail, Agnieszka K. Witkiewicz, & Erik S. Knudsen. (2018). Coordinately Targeting Cell-Cycle Checkpoint Functions in Integrated Models of Pancreatic Cancer. Clinical Cancer Research. 25(7). 2290–2304. 26 indexed citations

Witkiewicz, Agnieszka K., Sejin Chung, Rachel Brough, et al.. (2018). Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer. Cell Reports. 22(5). 1185–1199. 76 indexed citations

Knudsen, Erik S., Paris Vail, Uthra Balaji, et al.. (2017). Stratification of Pancreatic Ductal Adenocarcinoma: Combinatorial Genetic, Stromal, and Immunologic Markers. Clinical Cancer Research. 23(15). 4429–4440. 143 indexed citations

10.

Knudsen, Erik S., et al.. (2017). Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility. Gut. 67(3). 508–520. 66 indexed citations

11.

Adams, Thomas A., Paris Vail, Mehri Mollaee, et al.. (2017). Composite analysis of immunological and metabolic markers defines novel subtypes of triple negative breast cancer. Modern Pathology. 31(2). 288–298. 39 indexed citations

12.

Kerr, Iain D., Hannah C. Cox, Kelsey Moyes, et al.. (2017). Assessment of in silico protein sequence analysis in the clinical classification of variants in cancer risk genes. Journal of Community Genetics. 8(2). 87–95. 22 indexed citations

13.

Knudsen, Erik S., Jack Hutcheson, Paris Vail, & Agnieszka K. Witkiewicz. (2017). Biological specificity of CDK4/6 inhibitors: dose response relationship,in vivosignaling, and composite response signature. Oncotarget. 8(27). 43678–43691. 58 indexed citations

14.

Vail, Paris, Brian Morris, Kelsey Moyes, et al.. (2015). Comparison of locus-specific databases for BRCA1 and BRCA2 variants reveals disparity in variant classification within and among databases. Journal of Community Genetics. 6(4). 351–359. 36 indexed citations

15.

Rosenthal, Eric T., et al.. (2015). Exceptions to the rule: Case studies in the prediction of pathogenicity for genetic variants in hereditary cancer genes. Clinical Genetics. 88(6). 533–541. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact